Dasatinib crosses the blood-brain barrier and is an efficient therapy for central nervous system Philadelphia chromosome–positive leukemiaKimmo Porkka, Francis Y. F. Lee|Blood|2008Cited by 440
Targeting DDR2 enhances tumor response to anti–PD-1 immunotherapyMegan M. Tu, Dan Theodorescu, Robert T. Jones et al.|Science Advances|2019Cited by 126